Nevertheless, based on the association of the coexistence of these two bacteria with malignant transformation and metastasis of CRC and considering that formate may function as a major oncometabolite through the activation of AhR signaling, AhR inhibitors are of potential therapeutic interest in patients with CRC with both the bacteria detected [44]. This evidence concerns the gene AHR and colorectal carcinoma.